Assoc. Prof. Özge Vural Topuz is a board-certified nuclear medicine specialist with a medical degree from Istanbul University Cerrahpaşa Faculty of Medicine (2011). She brings clinical expertise in diagnostic and therapeutic nuclear medicine, combining patient-centered care with evidence-based practice. Since 2024 she has been affiliated with Acibadem Health Group, where she contributes to advanced imaging services, multidisciplinary care planning, and the application of modern nuclear medicine techniques. Her professional approach emphasizes accurate diagnosis, safety in radiopharmaceutical use, and clear communication with patients and clinical teams. She is committed to continuing education, clinical excellence, and collaborative work to improve patient outcomes through precise imaging and targeted therapies.
Education
- 2011 Istanbul University Cerrahpaşa Faculty of Medicine Nuclear Medicine
- 2006 Istanbul Bilim University Faculty of Medicine
Experience
- 2024 Acibadem Health Group
- 2024 Health Sciences University, Hamidiye Medical Faculty, Department of Nuclear Medicine
- 2020 – 2024 TC Ministry of Health Pine and Sakura City Hospital
- 2011 – 2020 MoHU Okmeydanı EAH /Nuclear Medicine specialist
Publications
- Can post neoadjuvantchemotherapy 18F-FDG PET/CT predict residual cancer burden in locally advanced breast cancer?
Medecine Nucleaire,2024;48(3),141-149. O.Vural Topuz, TS Akkurt, GU Erdem, E M Kaya, M Kaya, B EAkkaş. - Molecular Imaging in GIST and Primary Peritoneal Tumors
Nucl Med Semin. 2024 Jul;10(2):159-169. doi:10.4274/nts.galenos.2024.0013. ? Topuz ÖV. - Cervical Cancer Metastasis to the Stomach Masquerading as Primary Gastric Cancer: A Case Report of a Rare Metastasis Detected via 18F-FDG PET/CT.
Nuklearmedizin. 2024;63:221-223. Vural Topuz O, Bagbudar S. - Baseline Ga-68 PSMA PET-Derived Primary Tumor Parameters in Patients with Prostate Cancer and Their Association with Clinical Risk Stratification and Clinicopathologic Features.
World Journal of Nuclear Medicine (2024) Topuz Özge Vural and Ayşegül Aksu - A different perspective on 18F-FDG PET radiomics in colorectal cancer patients: The relationship between intra & peritumoral analysis and pathological findings.
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2023;42:359-366. Vural Topuz Ö, Aksu A, Yılmaz Özgüven MB - A Rare Case of Differentiated Thyroid Carcinoma with Liver Metastases.
Indian Journal of Nuclear Medicine, 2022;37:186-188. Topuz Özge Vural, Erhan S. S., Erinç S. R. & Tamam, M. Ö. - The Evaluation of Preoperative 18F-FDG PET/CT in Patients with Endometrial Cancer and the Correlation Between PET Parameters and Postoperative Patholo
Mol Imaging Radionucl Ther. 2022;31:16-22. Vural Topuz Ö, Aksu A, Erinç SR, Tokgözoğlu N, Tamam MÖ. - Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses.
Ann Nucl Med. 2022;36:310-318. Aksu A, Vural Topuz Ö, Yılmaz G, Çapa Kaya G, Yılmaz B. - Prediction of early biochemical response after 177Lu-PSMA radioligand therapy with 68Ga-PSMA PET, a different perspective with quantitative parameters
Nucl Med Commun. 2022;10.1097. Aksu A, Vural Topuz Ö, Yilmaz B, Karahan Sen NP, Acar E, Çapa Kaya G. - A case of soft tissue hematoma detected incidentally on 99m TC-labeled RBC gastrointestinal bleeding SPECT/CT. Technetium-99m-labeled RBC gastrointestinal
Ulus Trauma Emergency Surg. 2022;28:113-115. Erinç R, Vural Topuz Ö, Tamam MÖ
